Home
About
Overview
Sharing Data
ORCID
Help
History (49)
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?
Do we really need another epidermal growth factor receptor tyrosine kinase inhibitor in first-line treatment for patients with non-small-cell lung cancer and EGFR mutations?
Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanisms.
Disparate outcomes in nonsmall cell lung cancer by immigration status.
See All 49 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Disparate outcomes in nonsmall cell lung cancer by immigration status.
Disparate outcomes in nonsmall cell lung cancer by immigration status. Cancer Med. 2021 04; 10(8):2660-2667.
View in:
PubMed
subject areas
Aged
Carcinoma, Large Cell
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Combined Modality Therapy
Emigration and Immigration
Female
Follow-Up Studies
Humans
Lung Neoplasms
Male
Prognosis
Retrospective Studies
Socioeconomic Factors
Survival Rate
authors with profiles
Ravi Salgia